BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1190@pharmaconomics
DTSTAMP:20260707T015756Z
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260430
SUMMARY:GSK Approval — Exdensur
DESCRIPTION:A final FDA approval decision on Exdensur for severe asthma with an eosinophilic phenotype and nasal polyps is expected Apr 29\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1131399/000165495426004051/a2755c.htm\n\nTrack it: https://pharmaconomics.com/e/1190
URL:https://pharmaconomics.com/e/1190
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:GSK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR